International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
Age-related distribution of influenza B and vaccine match in the 2024-2025 season: A multi-season comparative analysis.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mandelboim Michal, Atari Nofar, Gur-Arie Lea, Sefty Hanna, Zuckerman Neta S, Kliker Limor, Dichtiar Rita, Nemet Ital, Nassar Shahd, Keinan-Boker Lital, Lustig Yaniv, Bromberg Michal, Glatman-Freedman Aharona, Israeli Respiratory Viruses Surveillance Networks
Аннотация
OBJECTIVES: The 2024-2025 season had the highest intensity of influenza-like illness in 13 seasons, and severe influenza B disease was reported by hospital physicians among children. These and the absence of influenza B/Yamagata after the COVID-19 pandemic prompted the evaluation of the 2024-2025 influenza cases by age group and influenza type, compared with previous seasons.
METHODS: Influenza-positive hospital and community cases for the 2024-2025 season and four previous seasons with influenza B circulation were retrieved from several data sources. Raw numbers and relative percentages of cases, including intensive or enhanced care unit, and 30-day mortality were evaluated by age group and influenza type. Molecular characterization of influenza viruses of the 2024-2025 season was compared with other seasons.
RESULTS: The 2024-2025 B/Victoria demonstrated molecular resemblance to the 2024-2025 vaccine. During the 2024-2025 season and other seasons with circulating and vaccine influenza B/lineage match, influenza B predominantly affected younger age groups. During seasons with circulating and vaccine influenza B/lineage mismatch, the percentage of influenza B cases among older age groups was not substantially different that the younger age groups. Influenza vaccination rates among children have been low throughout the evaluation period.
CONCLUSIONS: Increasing influenza vaccination among young age groups is paramount for reducing influenza morbidity.
METHODS: Influenza-positive hospital and community cases for the 2024-2025 season and four previous seasons with influenza B circulation were retrieved from several data sources. Raw numbers and relative percentages of cases, including intensive or enhanced care unit, and 30-day mortality were evaluated by age group and influenza type. Molecular characterization of influenza viruses of the 2024-2025 season was compared with other seasons.
RESULTS: The 2024-2025 B/Victoria demonstrated molecular resemblance to the 2024-2025 vaccine. During the 2024-2025 season and other seasons with circulating and vaccine influenza B/lineage match, influenza B predominantly affected younger age groups. During seasons with circulating and vaccine influenza B/lineage mismatch, the percentage of influenza B cases among older age groups was not substantially different that the younger age groups. Influenza vaccination rates among children have been low throughout the evaluation period.
CONCLUSIONS: Increasing influenza vaccination among young age groups is paramount for reducing influenza morbidity.